A randomized controlled trial showed that recombinant thrombomodulin (rhTM) had an increasing trend in survival in sepsis with suspected sepsis-associated DIC [ 11 ].
← all excerpts
Efficacy and safety of heparin for sepsis-induced disseminated intravascular coagulation (HepSIC): study protocol for a multicenter randomized controlled trial.
1
—
—